Literature DB >> 16978851

Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.

W Rösch1, T Liebregts, K-J Gundermann, B Vinson, G Holtmann.   

Abstract

Functional gastrointestinal disorders such as functional (or non-ulcer) dyspepsia are characterized by a broad spectrum of symptoms referred to the upper abdomen without a detectable cause utilizing routine diagnostic measures. It is now believed that disordered gut function (including abnormalities like disturbances of motility such as postprandial fundic relaxation, gastric emptying and disturbed visceral sensory function) play a key role for the manifestation of these disorders. The underlying pathophysiology is not yet fully understood. However, the available data suggest that a number of factors may contribute to the manifestation of symptoms. These factors include environmental factors such as acute infections as trigger event, psychological stressors that may precede acute exacerbations and a genetic predisposition. Considering the large number of mechanisms, a treatment targeting a single mechanism is unlikely to be effective in all patients. Indeed, chemically defined treatments usually gain a 10-15% superiority over placebo. In recent years placebo-controlled studies have demonstrated superiority of a commercial multicomponent herbal preparation, STW 5, with the trade name Iberogast, for the treatment of patients with functional dyspepsia and irritable bowel syndrome. This phytopharmacon is a combination of nine plant extracts each with a number of different active constituents. Pharmacological studies have shown different effects of the single plant extracts on the (molecular) mechanisms which are discussed as underlying the manifestation of symptoms. Various well-controlled clinical trials have independently confirmed clinical efficacy and safety. The clinically efficacy of this multicomponent herbal preparation questions the current trend of highly targeted drug molecules that usually target one single receptor population while it has not been shown that a single receptor group plays a pivotal role for the control of symptoms. Herbal medicines are obtained from various plants and contain complex extracts with a large number of different active substances. While there are only limited head-to-head comparisons with conventional chemically defined medications, the combination of extracts with various gastrointestinal active ingredients appears to be advantageous for a heterogeneous condition such as functional dyspepsia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16978851     DOI: 10.1016/j.phymed.2006.03.022

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  18 in total

1.  Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.

Authors:  Sebastian Michael; Heba Abdel-Aziz; Dieter Weiser; Christa E Müller; Olaf Kelber; Karen Nieber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-12-10       Impact factor: 3.000

2.  Functional dyspepsia.

Authors:  Rita Brun; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 3.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 4.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

Review 5.  [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome].

Authors:  Hans-Dieter Allescher; Hildebert Wagner
Journal:  Wien Med Wochenschr       Date:  2007

6.  The Pharmacological Effects of Benachio-F(®) on Rat Gastrointestinal Functions.

Authors:  Bijay Kumar Poudel; Jae Young Yu; Yong Sam Kwon; Hyoung Geun Park; Miwon Son; Joon Ho Jun; Jeong Ah Kim; Jong Oh Kim
Journal:  Biomol Ther (Seoul)       Date:  2015-07-01       Impact factor: 4.634

7.  Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Yang Won Min; Byung-Hoon Min; Seonwoo Kim; Dongil Choi; Poong-Lyul Rhee
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

8.  STW 5 is effective in dextran sulfate sodium-induced colitis in rats.

Authors:  Walaa Wadie; Heba Abdel-Aziz; Hala F Zaki; Olaf Kelber; Dieter Weiser; Mohamed T Khayyal
Journal:  Int J Colorectal Dis       Date:  2012-05-06       Impact factor: 2.571

9.  Phytotherapy of chronic abdominal pain following pancreatic carcinoma surgery: a single case observation.

Authors:  Karl Rüdiger Wiebelitz; André-Michael Beer
Journal:  Int J Gen Med       Date:  2012-10-16

Review 10.  DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia.

Authors:  Yong Sam Kwon; Miwon Son
Journal:  Biomol Ther (Seoul)       Date:  2013-05-30       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.